Author

Didier Scavarda

InsermORCID 0000-0001-9344-8071Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Agnès TrébuchoniD· 1 shared Andrew C. MerceriD· 1 shared Angélique PeretiD· 1 shared Anne Fabienne LepineiD· 1 shared April R. Giles· 1 shared Cécile MarchaliD· 1 shared Céline BoileauiD· 1 shared Christophe MulleiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Agnès TrébuchonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy

Céline Boileau, Séverine Deforges, Angélique Peret, Didier Scavarda, Fabrice Bartoloméi, April R. Giles, Nicolas Partouche, Justine Gautron, Julio Viotti, Haley N. Janowitz, Guillaume Penchet, Cécile Marchal, Stanislas Lagarde, Agnès Trébuchon, Nathalie Villeneuve, , Valérie Crépel

This study demonstrates that gene therapy targeting GluK2 reduces seizures in TLE models and patient-derived slices.

Annals of Neurology · Jun 21, 2023Peer-reviewedNeuroscience